These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

845 related items for PubMed ID: 27350407

  • 1. Impact of Depression on Health and Medical Care Utilization and Expenses in US Adults With Migraine: A Retrospective Cross Sectional Study.
    Wu J, Davis-Ajami ML, Kevin Lu Z.
    Headache; 2016 Jul; 56(7):1147-60. PubMed ID: 27350407
    [Abstract] [Full Text] [Related]

  • 2. Patterns of use and health expenses associated with triptans among adults with migraines.
    Wu J, Noxon V, Lu ZK.
    Clin J Pain; 2015 Aug; 31(8):673-9. PubMed ID: 25185875
    [Abstract] [Full Text] [Related]

  • 3. The medical costs of migraine and comorbid anxiety and depression.
    Pesa J, Lage MJ.
    Headache; 2004 Jun; 44(6):562-70. PubMed ID: 15186300
    [Abstract] [Full Text] [Related]

  • 4. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD, Lee L, Gandhi K, Fitzgerald T, Bell J, Cohen JM.
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [Abstract] [Full Text] [Related]

  • 5. Impact of migraine on health care utilization and expenses in obese adults: a US population-based study.
    Wu J, Davis-Ajami ML, Lu ZK.
    Clinicoecon Outcomes Res; 2019 Nov; 11():51-59. PubMed ID: 30643442
    [Abstract] [Full Text] [Related]

  • 6. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P.
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [Abstract] [Full Text] [Related]

  • 7. Nephrotoxic Medication Exposure in U.S. Adults with Predialysis Chronic Kidney Disease: Health Services Utilization and Cost Outcomes.
    Davis-Ajami ML, Fink JC, Wu J.
    J Manag Care Spec Pharm; 2016 Aug; 22(8):959-68. PubMed ID: 27459659
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a Diabetes Self-Management Program: Claims Analysis on Comorbid Illnesses, Health Care Utilization, and Cost.
    Turner RM, Ma Q, Lorig K, Greenberg J, DeVries AR.
    J Med Internet Res; 2018 Jun 22; 20(6):e207. PubMed ID: 29934284
    [Abstract] [Full Text] [Related]

  • 9. Multiple chronic conditions and associated health care expenses in US adults with cancer: a 2010-2015 Medical Expenditure Panel Survey study.
    Davis-Ajami ML, Lu ZK, Wu J.
    BMC Health Serv Res; 2019 Dec 19; 19(1):981. PubMed ID: 31856797
    [Abstract] [Full Text] [Related]

  • 10. Differences in health services utilization and costs between antihypertensive medication users versus nonusers in adults with diabetes and concomitant hypertension from Medical Expenditure Panel Survey pooled years 2006 to 2009.
    Davis-Ajami ML, Wu J, Fink JC.
    Value Health; 2014 Dec 19; 17(1):51-61. PubMed ID: 24438717
    [Abstract] [Full Text] [Related]

  • 11. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM.
    Headache; 2011 Dec 19; 51(7):1058-77. PubMed ID: 21762134
    [Abstract] [Full Text] [Related]

  • 12. Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel survey.
    Ford JH, Ye W, Nichols RM, Foster SA, Nelson DR.
    J Med Econ; 2019 Sep 19; 22(9):849-858. PubMed ID: 30977712
    [Abstract] [Full Text] [Related]

  • 13. Depression and anxiety: effect on the migraine-obesity relationship.
    Tietjen GE, Peterlin BL, Brandes JL, Hafeez F, Hutchinson S, Martin VT, Dafer RM, Aurora SK, Stein MR, Herial NA, Utley C, White L, Khuder SA.
    Headache; 2007 Jun 19; 47(6):866-75. PubMed ID: 17578537
    [Abstract] [Full Text] [Related]

  • 14. Emotional Abuse History and Migraine Among Young Adults: A Retrospective Cross-Sectional Analysis of the Add Health Dataset.
    Tietjen GE, Karmakar M, Amialchuk AA.
    Headache; 2017 Jan 19; 57(1):45-59. PubMed ID: 27917478
    [Abstract] [Full Text] [Related]

  • 15. A retrospective matched case-control study on medical costs of refractory migraine in Taiwan.
    Tang CH, Chen YC, Ng K, Wang SJ.
    Headache; 2013 Mar 19; 53(3):526-39. PubMed ID: 23406446
    [Abstract] [Full Text] [Related]

  • 16. Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.
    McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.
    J Clin Psychiatry; 2006 Aug 19; 67(8):1187-93. PubMed ID: 16965195
    [Abstract] [Full Text] [Related]

  • 17. Allodynia in migraine: association with comorbid pain conditions.
    Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA.
    Headache; 2009 Oct 19; 49(9):1333-44. PubMed ID: 19788473
    [Abstract] [Full Text] [Related]

  • 18. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB, Buse DC, Saiers J, Serrano D, Reed ML.
    J Med Econ; 2013 Oct 19; 16(4):490-9. PubMed ID: 23356422
    [Abstract] [Full Text] [Related]

  • 19. Patterns of use and expenses associated with mail-service pharmacy in adults with diabetes.
    Wu J, Davis-Ajami ML, Noxon V.
    J Am Pharm Assoc (2003); 2015 Oct 19; 55(1):41-51. PubMed ID: 25539092
    [Abstract] [Full Text] [Related]

  • 20. Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United States.
    Varnado OJ, Vu M, Buysman E, Kim G, Allenback G, Hoyt M, Trenz H, Cao F, Viktrup L.
    J Manag Care Spec Pharm; 2024 Aug 19; 30(8):792-804. PubMed ID: 39088336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.